Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
BJU International
|
June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
Cancer
|
March 29, 2016
Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer
Shi-Ming Tu, Mehmet Asim Bilen, Kenneth R Hess, et al.
BJU International
|
September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort
Pierre Blanchard, John W Davis, Steven J Frank, et al.
Urologic Oncology
|
March 7, 2021
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus
Wei Phin Tan, Ardeshir R Rastinehad, Laurence Klotz, et al.
European Urology
|
June 14, 2020
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus
Amir H Lebastchi, Arvin K George, Thomas J Polascik, et al.
Biomarker Research
|
November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
Justin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Urologic Oncology
|
August 2, 2015
Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design
Willemien van den Bos, Berrend G Muller, Daniel M de Bruin, et al.
European Urology Focus
|
November 17, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study
Alireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORS
Yago Nieto, John F Ward, Wayne Hofstetter, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
BJU International
|
June 5, 2024
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates
Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, et al.
Cancer
|
March 29, 2016
Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer
Shi-Ming Tu, Mehmet Asim Bilen, Kenneth R Hess, et al.
BJU International
|
September 24, 2017
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort
Pierre Blanchard, John W Davis, Steven J Frank, et al.
Urologic Oncology
|
March 7, 2021
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus
Wei Phin Tan, Ardeshir R Rastinehad, Laurence Klotz, et al.
European Urology
|
June 14, 2020
Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus
Amir H Lebastchi, Arvin K George, Thomas J Polascik, et al.
Biomarker Research
|
November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
Justin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Urologic Oncology
|
August 2, 2015
Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design
Willemien van den Bos, Berrend G Muller, Daniel M de Bruin, et al.
European Urology Focus
|
November 17, 2024
Oncological Outcomes Following Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study
Alireza Ghoreifi, Farshad Sheybaee Moghaddam, Anirban P Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORS
Yago Nieto, John F Ward, Wayne Hofstetter, et al.
Page
of 11